The Cancer Genome Atlas (TCGA) comprehensive GBM molecular characterizations have identified significant genetic alterations in several important oncogenic signalling pathways such as the RTK/Ras/PI3K (88%), p53 (87%) and pRB signalling pathways (78%) in GBM patients [9]. Here, RB1 is linked to glioblastoma.